Schizophrenia is a relatively common disease whose lifetime prevalence in the general population is reported to be about 1%. From the perspective of public health, the illness has been associated with serious consequences. Besides psychotic symptoms, schizophrenia is characterised by disturbances of cognitive function, which is considered to largely determine the outcome of patients. The neural and genetic substrates underlying its pathophysiology have not been fully demarcated, posing a challenge for the development of breakthrough therapeutics. This book provides key information about the latest endeavour to solve these difficulties characterising this enigmatic disease.
Preface; A model-based approach to schizophrenia research; How could the degree of the linearity of the Brief Psychiatric Rating Scale be measured & improved:: A retrospective analysis; Quality of life & personal & social functioning:: New targets in schizophrenia treatment; Natural-mortality in schizophrenia:: An updated meta-analysis; Psychiatric nurses beliefs about the treatability of schizophrenia.
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.